(Q36408945)

14 August 2017

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe (English)

1 reference

14 August 2017

0 references

0 references

0 references

anti-retroviral agent

0 references

Charles F Gilks

8

0 references

Elly Katabira

series ordinal

7

object named as

Elly Katabira

1 reference

14 August 2017

9

Cissy Kityo

1 reference

14 August 2017

3

Peter Mugyenyi

1 reference

14 August 2017

12

Diana M Gibb

1 reference

14 August 2017

1

A Sarah Walker

1 reference

14 August 2017

11

Kusum Nathoo

1 reference

14 August 2017

4

Paula Munderi

1 reference

14 August 2017

6

Addy Kekitiinwa

1 reference

14 August 2017

Patricia Nahirya-Ntege

series ordinal

10

object named as

Patricia Nahirya-Ntege

1 reference

14 August 2017

2

Andrew J Prendergast

1 reference

14 August 2017

James Hakim

5

1 reference

14 August 2017

DART and ARROW trial teams

series ordinal

13

1 reference

14 August 2017

language of work or name

English

0 references

publication date

12 September 2012

1 reference

Clinical Infectious Diseases

14 August 2017

1 reference

14 August 2017

55

1 reference

14 August 2017

12

1 reference

14 August 2017

1707-1718

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

14 August 2017

start time

3 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Mortality and loss to follow-up in the first year of ART: Malawi national ART programme

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Changing predictors of mortality over time from cART start: implications for care

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

The charms and challenges of antiretroviral therapy in Uganda: the DART experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Survival of HIV-infected children: a cohort study from the Asia-Pacific region

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Definition and epidemiology of late presentation in Europe

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Early mortality and cause of deaths in patients using HAART in Brazil and the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Antiretroviral therapy and early mortality in South Africa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Development of a WHO growth reference for school-aged children and adolescents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Treatment of latent tuberculosis infection in HIV infected persons

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Cryptococcosis in human immunodeficiency virus-infected children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

28 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Late presentation of HIV infection among adults in New Zealand: 2005-2010.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501336

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

21 September 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Current CD4 Cell Count and the Short‐Term Risk of AIDS and Death before the Availability of Effective Antiretroviral Therapy in HIV‐Infected Children and Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS797

Late presentation for HIV diagnosis and care in Germany

21 January 2018

1 reference

12 December 2020

Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting

1 reference

12 December 2020

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

12 December 2020

Cryptococcosis in children with AIDS

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIS797

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22972859

1 reference